retatrutide dosing clinical trial retatrutide Phase III study demonstrates 30% weight loss VisualAbstract: Retatrutide reduces body weight

Americans are among the most overweight people on the planet, and obesity leads to all manner of life-threatening ills type 2 diabetes, serious cardiovascular events like heart attacks and strokes, numerous cancers, and sleep apnea, to name a few

doi: 10.1016/j.eclinm.2021.100979 99 GorelikYGhersinILujanRShlonDLoewenberg WeisbandYBen-TovAet al

Henry Meds healthcare providers offer professional, individualized support to help you reach your health and lifestyle goals

In one trial of people with obesity and knee osteoarthritis, top-line results released in late 2025 showed that those receiving 12 mg weekly achieved 2226% average weight loss over 68 weeks , while the placebo group lost only around 2.5%